title: The relative reinforcing strength of methamphetamine and D-amphetamine in monkeys self-administering cocaine.
abstract: Epidemiological data indicate that rates of methamphetamine misuse surpass those of D-amphetamine, but self-administration research in animals and humans has not typically demonstrated differences in their reinforcing effects. The present study used a within-session, exponentially increasing progressive-ratio schedule and extended-access conditions to assess the relative reinforcing strength of D-amphetamine and methamphetamine in rhesus monkeys (n=5) trained to self-administer cocaine. A range of doses of methamphetamine (0.003-0.1 mg/kg/injection), D-amphetamine (0.003-0.1 mg/kg/injection), and cocaine (0.003-0.3 mg/kg/injection) was tested to capture the ascending and descending limbs of the dose-effect functions. Each drug functioned as a reinforcer, but the peak number of self-administered D-amphetamine injections was significantly lower compared with methamphetamine and cocaine; the peak number of self-administered injections of cocaine and methamphetamine did not differ. Although differences in availability and other social factors likely impact relative rates of abuse, the present data suggest that the greater reinforcing strength of methamphetamine contributes to its increased use compared with D-amphetamine.
authors.affiliation: Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1083, USA.
authors.forename: Joshua A
authors.initials: JA
authors.lastname: Lile
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Charnigo
authors.forename: Michael A
authors.initials: MA
authors.lastname: Nader
mesh_terms: D000818:Animals; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D003042:Cocaine / Q000008:administration & dosage*; D003216:Conditioning, Operant / Q000187:drug effects; D003913:Dextroamphetamine / Q000494:pharmacology*; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage*; D008253:Macaca mulatta; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology*; D012054:Reinforcement, Psychology; D012646:Self Administration
chemical_list: D000697:Central Nervous System Stimulants; D018765:Dopamine Uptake Inhibitors; D008694:Methamphetamine; D003042:Cocaine; D003913:Dextroamphetamine
references.citation: Psychopharmacology (Berl). 2003 Feb;165(4):359-69
references.pmid: 12491026
references.citation: J Pharmacol Exp Ther. 1973 Oct;187(1):27-33
references.pmid: 4795731
references.citation: Behav Pharmacol. 1990;1(4):283-301
references.pmid: 11175414
references.citation: Exp Clin Psychopharmacol. 2006 Feb;14(1):20-33
references.pmid: 16503702
references.citation: Pharmacol Biochem Behav. 1973 Jan-Feb;1(1):67-71
references.pmid: 4204513
references.citation: Exp Clin Psychopharmacol. 2011 Apr;19(2):95-104
references.pmid: 21463066
references.citation: Anal Biochem. 2007 Feb 15;361(2):236-43
references.pmid: 17178092
references.citation: Pharmacol Biochem Behav. 1976 Jan;4(1):45-51
references.pmid: 4818
references.citation: Psychopharmacologia. 1969;16(1):30-48
references.pmid: 4982648
references.citation: Clin Pharmacol Ther. 2003 Nov;74(5):475-86
references.pmid: 14586388
references.citation: J Pharmacol Exp Ther. 2002 Nov;303(2):640-8
references.pmid: 12388646
references.citation: J Pharmacol Exp Ther. 2003 Oct;307(1):356-66
references.pmid: 12954808
references.citation: Adv Pharmacol Sci. 2012;2012:281768
references.pmid: 23243420
references.citation: Addiction. 2012 Apr;107(4):783-91
references.pmid: 22050030
references.citation: Prim Care. 2011 Mar;38(1):41-58
references.pmid: 21356420
references.citation: J Neurosci Methods. 1996 May;66(1):1-11
references.pmid: 8794935